Clinical trial
Efficacy and Safety Study of E2007 in Migraine Prophylaxis
NCT00154063 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00154063 |
|---|---|
| Title | Efficacy and Safety Study of E2007 in Migraine Prophylaxis |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 in Migraine Prophylaxis |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine Prophylaxis |
| Intervention type | Drug, Other |
| Interventions | E2007, Placebo |
| Enrollment | 206 |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: